Peter D. Byeff
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
-
- Multiple Myeloma Research and Treatments 2
- Acute Myeloid Leukemia Research 1
- Blood groups and transfusion 1
-
- Multiple Sclerosis Research Studies 1
- Lymphoma Diagnosis and Treatment 1
- Co-authors
- Már Kristjánsson (1 shared paper)Leonard Chess (1 shared paper)Daniel M. Knowles (1 shared paper)James P. Halper (1 shared paper)J. D. OWEN (1 shared paper)Roy R. Hantgan (1 shared paper)
- Journals
- The Lancet Oncology (2 papers)JAMA (1 paper)American Journal of Hematology (1 paper)Blood Coagulation & Fibrinolysis (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Peter D. Byeff
8 papers receiving 889 citations
Peter D. Byeff's Hit Papers
Peers
Comparison fields: 5 of 62
- Hematology 313
- Oncology 470
- Cancer Research 143
- Genetics 71
- Radiology, Nuclear Medicine and Imaging 114
Countries citing papers authored by Peter D. Byeff
This map shows the geographic impact of Peter D. Byeff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter D. Byeff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter D. Byeff more than expected).
Fields of papers citing papers by Peter D. Byeff
This network shows the impact of papers produced by Peter D. Byeff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter D. Byeff. The network helps show where Peter D. Byeff may publish in the future.
Co-authors
The 6 scholars most cited alongside Peter D. Byeff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 461 |
| 2 | Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2019 | 316 |
| 3 | 1991 | 65 | |
| 4 | 2019 | 31 | |
| 5 | 1982 | 18 | |
| 6 | 2020 | 13 | |
| 7 | 1976 | 7 | |
| 8 | 1994 | 1 |
About Peter D. Byeff
Peter D. Byeff is a scholar working on Hematology, Pathology and Forensic Medicine, Otorhinolaryngology, Microbiology and Dermatology, having authored 8 papers that have together received 912 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (2 papers), Acute Myeloid Leukemia Research (1 paper), Multiple Sclerosis Research Studies (1 paper), Tuberculosis Research and Epidemiology (1 paper), T-cell and Retrovirus Studies (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Blood groups and transfusion (1 paper) and Cutaneous lymphoproliferative disorders research (1 paper). The work is most often cited by research in Hematology (313 citations), Oncology (470 citations), Cancer Research (143 citations), Genetics (71 citations) and Radiology, Nuclear Medicine and Imaging (114 citations). Peter D. Byeff has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Már Kristjánsson, Leonard Chess, Daniel M. Knowles, James P. Halper, J. D. OWEN and Roy R. Hantgan. Their work appears in journals such as The Lancet Oncology, JAMA, American Journal of Hematology, Blood Coagulation & Fibrinolysis and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.